Fridays vs MEDVi: Which GLP-1 Provider Is Better?
Short answer: Fridays scores higher on our rubric, 8.7/10 against 5.7/10. Full reasoning, pricing and the cases where the other one wins are below.
Fridays beats MEDVi overall, scoring 8.7/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: Fridays is from $117/mo; MEDVi is $179 first month, then $299/mo. Choose Fridays for users who want a holistic program with coaching, nutrition support, and flexible pricing. Choose MEDVi for users who want both oral and injectable compounded options in one telehealth program.
A side-by-side look at Fridays and MEDVi to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Fridays
#1 of 34Holistic weight loss program combining GLP-1 medications with lifestyle coaching, nutrition guidance, and ongoing support.
Visit FridaysMEDVi
#25 of 34MEDVi offers a weekly compounded GLP-1 injection and a daily compounded tablet. The injection is $179 for month one and $299 for refills. Trustpilot is 4.3 out of 5 across 14,680 reviews, while BBB is F/not accredited. FDA warning letter #721455 concerns misleading labeling and marketing, not an allegation that the medication was unsafe.
Visit MEDVi| Feature | Fridays | MEDVi |
|---|---|---|
| Why each one | A bundled program rather than a prescribe and ship service. Unlimited provider visits, nutrition and mental health coaching and 1-on-1 dietitian support are included in the monthly price with no separate membership fee, and compounded and brand-name GLP-1s are sold side by side on the same page. | A daily dissolvable GLP-1 tablet and a weekly compounded injection in one program, plus brand-name Wegovy and Zepbound on a $99 membership. |
| Our Score | 8.7/10 | 5.7/10 |
| Headline Price | from $117/mo | $179 first month, then $299/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
| Best For | Users who want a holistic program with coaching, nutrition support, and flexible pricing | Users who want both oral and injectable compounded options in one telehealth program |
| Watch out for | The lowest advertised compounded prices require an annual commitment and a promo code | FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication |
| Ranking | #1 | #25 |
| Get started | Visit Fridays | Visit MEDVi |
Pros & Cons Compared
Fridays
Pros
- +Compounded semaglutide runs as low as $117 a month on the annual plan with the NYNY12 code printed on its pricing page, against $279 month to month
- +Includes 1-on-1 nutrition coaching and weekly check-ins, not just medication prescriptions
- +Sells brand-name Ozempic, Zepbound and Wegovy alongside compounded semaglutide and tirzepatide, with an insurance concierge that helps you pursue coverage for the brand-name option through your own plan
- +Membership costs nothing on top of the medication price: unlimited provider visits, nutrition and mental health coaching and 1-on-1 dietitian support are listed on every plan
Cons
- −The lowest advertised compounded prices require an annual commitment and a promo code
- −Compounded medication and virtual visits are cash-pay. Fridays offers insurance and prior-authorization support for brand-name medication, but coverage and your out-of-pocket cost depend on your plan.
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +The landing page says the program is HSA and FSA eligible and includes dietician visits and care coaching, with a footnote making that subject to insurance and copay eligibility
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179 covers the first month of compounded semaglutide on MEDVi's landing page, including physician review, the personalized plan, medication and free shipping
Cons
- −FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
- −Its third-party records conflict: 4.3 out of 5 across 14,680 Trustpilot reviews with 12 percent of them at one star, against an F and no accreditation at the BBB
- −The $179 semaglutide price covers month one only; the FAQ on MEDVi's own landing page says refills are locked in at $299 a month, making the first year $3,468 rather than $2,148
- −Brand-name Wegovy and Zepbound paths add a $99 membership plus a medication cost the page does not publish, and the same page's hero says "No membership or hidden fees!" directly above those cards; availability is subject to change
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Our Verdict
Fridays edges out MEDVi with a score of 8.7/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: Fridays is from $117/mo; MEDVi is $179 first month, then $299/mo.
Reviews and pricing sources
Related comparisons
More head-to-head comparisons involving Fridays and MEDVi.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Compare Fridays and Foundpublished $148/mo; total not verified
- Compare Fridays and Luvo Healthfrom $249/mo
- Compare Fridays and Maximuspublished $79.99/mo; total not verified
- Compare MEDVi and Wellorithmfrom $147/mo
- Compare MEDVi and Sprout Health$110/mo flat
- Compare MEDVi and Eden Health GLP-1$99/mo month-to-month
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Fridays legit and is MEDVi legit, with the verification evidence behind each answer.
Our pick of these two: Fridays · 8.7/10